Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD)
Introduction A 47 y.o. female patient was admitted to the female PICU with a manic episode. Upon admission she presented with mood elation, psychosis, pressured speech, lack of sleep and agitation. Objectives To investigate negative prognostic factors such as the co-morbidity with a personality...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2021-04-01
|
| Series: | European Psychiatry |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S092493382101662X/type/journal_article |
| _version_ | 1797617154339635200 |
|---|---|
| author | A. Sarafopoulos D. Antoniadis V. Karpouza |
| author_facet | A. Sarafopoulos D. Antoniadis V. Karpouza |
| author_sort | A. Sarafopoulos |
| collection | DOAJ |
| description |
Introduction
A 47 y.o. female patient was admitted to the female PICU with a manic episode. Upon admission she presented with mood elation, psychosis, pressured speech, lack of sleep and agitation.
Objectives
To investigate negative prognostic factors such as the co-morbidity with a personality disorder in patients presenting with severe mania.
Methods
The patient was assessed regularly by the psychiatric team consisting of a CT doctor and one General Adult Consultant. Appropriate psychological assessments for mania and laboratory investigations took place.
Results
The patient initially scored above 45 in the Young Mania Rating Scale (YMRS), establishing a diagnosis of severe mania. She was treated with Olanzapine titrated up to 20mg OD and augmentation with Lithium treatment. Lithium plasma levels were at 0,6. Due to the treatment resistant manic presentation a second antipsychotic agent was administered and the patient was also treated with Zuclopenthixol depot 400mg every two weeks. Clinical improvement was observed after 16 days from admission.
Conclusions
The clinical team wondered about the clinical challenges of the case. According to the literature having a Personality Disorder diagnosis is a negative prognostic factor for patients with mania and this is relevant to this case as well.
Disclosure
No significant relationships.
|
| first_indexed | 2024-03-11T07:51:48Z |
| format | Article |
| id | doaj.art-b4cd1fee192a4097b11cc1fbe602ee9c |
| institution | Directory Open Access Journal |
| issn | 0924-9338 1778-3585 |
| language | English |
| last_indexed | 2024-03-11T07:51:48Z |
| publishDate | 2021-04-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | European Psychiatry |
| spelling | doaj.art-b4cd1fee192a4097b11cc1fbe602ee9c2023-11-17T05:06:39ZengCambridge University PressEuropean Psychiatry0924-93381778-35852021-04-0164S625S62510.1192/j.eurpsy.2021.1662Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD)A. Sarafopoulos0D. Antoniadis1V. Karpouza24th Picu, Psychiatric Hospital of Thessaliniki, Thessaloniki, Greece4th Picu, Psychiatric Hospital of Thessaloniki, Thessaloniki, Greece4th Picu, Psychiatric Hospital of Thessaloniki, Thessaloniki, Greece Introduction A 47 y.o. female patient was admitted to the female PICU with a manic episode. Upon admission she presented with mood elation, psychosis, pressured speech, lack of sleep and agitation. Objectives To investigate negative prognostic factors such as the co-morbidity with a personality disorder in patients presenting with severe mania. Methods The patient was assessed regularly by the psychiatric team consisting of a CT doctor and one General Adult Consultant. Appropriate psychological assessments for mania and laboratory investigations took place. Results The patient initially scored above 45 in the Young Mania Rating Scale (YMRS), establishing a diagnosis of severe mania. She was treated with Olanzapine titrated up to 20mg OD and augmentation with Lithium treatment. Lithium plasma levels were at 0,6. Due to the treatment resistant manic presentation a second antipsychotic agent was administered and the patient was also treated with Zuclopenthixol depot 400mg every two weeks. Clinical improvement was observed after 16 days from admission. Conclusions The clinical team wondered about the clinical challenges of the case. According to the literature having a Personality Disorder diagnosis is a negative prognostic factor for patients with mania and this is relevant to this case as well. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S092493382101662X/type/journal_articlemaníaBPD |
| spellingShingle | A. Sarafopoulos D. Antoniadis V. Karpouza Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD) European Psychiatry manía BPD |
| title | Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD) |
| title_full | Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD) |
| title_fullStr | Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD) |
| title_full_unstemmed | Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD) |
| title_short | Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD) |
| title_sort | treatment resistant manic episode with commorbidity with borderline personality disorder bpd |
| topic | manía BPD |
| url | https://www.cambridge.org/core/product/identifier/S092493382101662X/type/journal_article |
| work_keys_str_mv | AT asarafopoulos treatmentresistantmanicepisodewithcommorbiditywithborderlinepersonalitydisorderbpd AT dantoniadis treatmentresistantmanicepisodewithcommorbiditywithborderlinepersonalitydisorderbpd AT vkarpouza treatmentresistantmanicepisodewithcommorbiditywithborderlinepersonalitydisorderbpd |